Results 51 to 60 of about 8,933 (160)

Prescribing trends for dabigatran etexilate in primary care. [PDF]

open access: yes, 2012
At the time of the analysis, dabigatran etexilate was licensed, in Ireland, for thromboprophylaxis in adults after elective total hip- and total knee-replacement only.
McCullagh, L, Barry, M
core  

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation [PDF]

open access: yes, 2011
Objective To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant, versus warfarin and other alternatives for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation (AF).
Pan, Feng   +6 more
core   +1 more source

Design and rationale of dabigatran's stroke prevention in real life in Turkey (D-SPIRIT)

open access: yesTürk Kardiyoloji Derneği Arşivi, 2016
Objective: The D-SPIRIT registry is designed to investigate the safety and efficacy of dabigatran etexilate in patients with nonvalvular atrial fibrillation (NVAF) and to collect data on outcomes in clinical practice.
Uğur Önsel Türk   +14 more
doaj   +1 more source

Stability of Dabigatran Etexilate in Manufacturer’s Blister Pack, Unit-Dose Packaging, and Community Pharmacy Blister Pack [PDF]

open access: yes, 2015
Background: Dabigatran, a direct thrombin inhibitor, is indicated for the prevention and treatment of venous thromboembolism and for stroke prophylaxis in atrial fibrillation.
Semchuk, William   +4 more
core   +1 more source

Spinal subarachnoid and subdural hematoma presenting as a Brown-Séquard-like myelopathy following minor trauma in a patient on dabigatran etexilate

open access: yesRadiology Case Reports, 2017
Dabigatran etexilate is a relatively new anticoagulant from the class of direct thrombin inhibitors which is administered orally and does not require routine blood work monitoring.
Allen R. Wolfe, MD, MPH   +5 more
doaj   +1 more source

A Comprehensive Disproportionality Analysis of Drug‐Related Head Injury Reports Using the FAERS Database

open access: yesBrain and Behavior, Volume 16, Issue 6, June 2026.
ABSTRACT Objective This study aimed to identify and characterize drugs associated with reports of head injury through a comprehensive analysis of the FDA Adverse Event Reporting System (FAERS) database. Methods A retrospective disproportionality analysis was conducted on FAERS reports from 2004 to 2023.
Jiaqi Guo   +5 more
wiley   +1 more source

Induction of cytochrome P450 2C9 and P‐glycoprotein activity by antiseizure medications: A systematic review and network meta‐analysis

open access: yesEpileptic Disorders, Volume 28, Issue 3, Page 855-867, June 2026.
Abstract Objectives Antiseizure medications (ASMs) can induce the activity of drug‐metabolizing enzymes and drug transporters, including cytochrome P450 (CYP)2C9 and P‐glycoprotein (P‐gp). Our objective was to comparatively assess the effects of ASMs on exposure to clinical CYP2C9 and P‐gp substrates.
Hagar Cohen   +4 more
wiley   +1 more source

Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation [PDF]

open access: yes, 2015
dabigatran etexilate, warfarin, oral anticoagulation, atrial fibrillation, efficacy, safety.Introduction Oral anticoagulation is the mainstay for stroke and thromboembolic events prevention in patients with atrial fibrillation (AF).
Dzeshka, M. S., Lip, G. Y.
core  

The effects of dabigatran etexilate on fracture healing in rats An experimental study

open access: yes, 2015
Yenilmez, Engin/0000-0002-0755-4394; Kerimoglu, Gokcen/0000-0002-4349-7796Background: Deep vein thrombosis leading to pulmonary embolism is one of the major complication after fracture. After a fracture occurs, the coagulation cascade activates thrombin,
Onay, Atılgan   +8 more
core   +1 more source

Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients with Atrial fibrillation : the IDEA Study [PDF]

open access: yes, 2019
BACKGROUND AND OBJECTIVES: Warfarin-related nephropathy is an unexplained acute kidney injury, and may occur in patients with supratherapeutic INR, in the absence of overt bleeding.
Polo Friz, Hernan   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy